SciELO - Scientific Electronic Library Online

 
vol.58 issue7Malignant melanoma of the penis: Report on one caseAdenocarcinoma of the female urethra: report of two cases and bibliography review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Archivos Españoles de Urología (Ed. impresa)

Print version ISSN 0004-0614

Abstract

PEREZ FENTES, Daniel et al. Brucellar orchyoepididymitis: case report. Arch. Esp. Urol. [online]. 2005, vol.58, n.7, pp.674-677. ISSN 0004-0614.

OBJECTIVES: To report one case of unilateral acute orchiepididymitis due to Brucella and to review its diagnosis and treatment in the related literature. METHOD: We report the case of a 37-year-old-male with undulant fever, scrotal pain and swelling and osteoarticular involvement. Diagnosis was obtained by anamnesis, blood cultures and specific serologic tests for Brucella. RESULTS: Antibiotic therapy with orally administered Doxycycline (6 weeks) and im-administered Streptomycin (3 weeks). Complete clinical resolution was achieved. CONCLUSIONS: We must perform an exhaustive anamnesis looking for a history of contact with animals or ingestion of contaminated dairy products in endemic areas of Brucella when facing the case of orchiepididymitis resistant to usual antibiotic therapy. The diagnosis is based on Brucella spp. isolation in blood cultures and on positive serologic tests (Rose Bengal test, standard seroagglutination test, anti-Brucella Coombs test, Brucellacapt test). Doxycycline with Streptomycin or Rifampin for 6 weeks seems to be the most adequate combinations of antibiotics. Surgical treatment only in exceptional cases.

Keywords : Orchiepididymitis; Brucella; Diagnosis; Treatment.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License